drugset / Trial / NCT01914965
Apathy Cure Through Bupropion in Huntington's Disease
Phase 2
Completed
40 enrolled
Charite University, Berlin, Germany
Ruhr University of Bochum · collabUniversity Hospital Muenster · collabUniversity of Ulm · collab
RandomizedCrossoverTriple-blindTreatment
Summary
The influence of bupropion compared to placebo on the change of apathy as quantified by the apathy evaluation scale (AES-I, where I \[informant\] is a friend or family member familiar with the daily activities of the subject) in patients with HD after ten (10) weeks of treatment.
Timeline
- Start
- 2012-06
- Primary completion
- 2014-05
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupropion | Small molecule | 300 mg | Oral |